SPAGO NANOMEDICAL ABSPAGO NANOMEDICAL ABSPAGO NANOMEDICAL AB

SPAGO NANOMEDICAL AB

No trades
See on Supercharts

SPAGO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The firm focuses on the development of nanomaterials for tumor diagnostics and treatment of cancer. Its projects include SpagoPix and Tumorad. The company was founded IN 2007 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

SPAGO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company